TP-IAT transplant with your own cells for type 1 diabetes
Part of Digestive system clinical trials.
This early-stage study tests whether adding your own special cells (mesenchymal stromal cells) at the same time as a TP-IAT transplant can improve diabetes outcomes. It may help people who are already planning TP-IAT, but it is only for certain age, diabetes, and health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic pancreatitis and are scheduled for TP-IAT
- You must be 18 years or older
- Your diabetes blood sugar test (HbA1c) must be under 12%
- You should not be taking immunosuppressing medicines right now
- You must not be pregnant or breastfeeding
- You must not have major liver problems (based on ALT, AST, and bilirubin more than 3 times the normal limit)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a treatment works after islet cell transplantation done for people with long-term (chronic) pancreatitis. It may help doctors better understand graft (transplant) function and how to choose the best approach and follow-up.
This trial tests a two-part surgery: removing the pancreas and then putting the patient’s own insulin-making cells back into the body to help control long-term pancreatitis pain. It is aimed at adults with severe, long-lasting pain who have not improved with medicines or procedures.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.